Introduction
The rapid emergence of antibiotic resistance threatens effective prevention and treatment of an increasing range of infections. Some bacteria are naturally resistant to certain antibiotics and others can acquire resistance through mutations in some of their genes when they are exposed to an antibiotic. This acquired resistance can spread to other bacterial species. The main mechanism of antibiotic resistance mostly found is enzyme production such as β-lactamase enzymes. The β-lactamase enzymes produced by some bacteria provide resistance to β-lactam antibiotics by hydrolyzing β-lactam rings. 
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Bubpamala et al Among antimicrobial resistant bacteria, Escherichia coli is one of highly concerned bacteria in the family Enterobacteriaceae. E. coli is a common cause of urinary tract infection and intra-abdominal infection in humans and is the second most common Gram-negative bacteria causing communityacquired bloodstream infection, accounting for 7.3% of all bloodstream infection isolates.
2 ESBL-producing E. coli isolates have become an importance in community-onset infections, as well as nosocomial infections. The prevalence of resistance to fluoroquinolones and extended-spectrum cephalosporins in E. coli had highly increased over the past decade rendering severely limited therapeutic options for these infections. Extended-spectrum β-lactamases (ESBLs) are extremely broad spectrum β-lactamase enzymes, which can be produced by Gram-negative bacteria. They are mainly found in a family of Enterobacteriaceae. ESBLs are produced by the mutation of the TEM-1, TEM-2, and SHV-1 β-lactamases, which have been discovered since 1980-1990 and first detected in Western Europe. 4 To date, more than 350 different natural ESBL variants are known, which have been classified into nine distinct structural and evolutionary families based on amino acid sequence comparisons such as TEM, SHV, CTX-M, PER, VEB, GES, BES, TLA, and OXA. [5] [6] [7] The main types of ESBL variants include TEM, SHV, CTX-M, and OXA. Interestingly, bla CTX−M has rapidly increased and is now widely found in clinically isolated E. coli across the world. 8 ESBLs, especially of the CTX-M type, are strongly associated with specific clonal E. coli strains. 9 To date, little is known about the epidemiology of ESBL variants in Thailand. Moreover, it is critical to provide up-to-date resistance pattern which affect the treatment decision in this region. Therefore, this study was aimed to investigate the phenotypic characteristic and variation of genetically related ESBL-producing E. coli in Thailand.
Material and methods

Bacterial isolates
ESBL-producing E. coli isolates were collected from tertiary care hospitals located in various regions in Thailand from 2014 to 2015. Tertiary care hospitals were defined over 500-bed hospitals that usually provided a full complement of services. These hospitals were regional hospitals which were generally referral for patients with serious conditions. A total of 285 E. coli isolates were obtained from clinical specimens, including urine, sputum, pus, blood, and feces, which were a part of routine hospital procedures. Confirmation and identification of E. coli strains were performed by biochemical tests and MALDI-TOF mass spectrometry. Determination of esBl-producing E. coli isolates ESBL-producing E. coli was screened with disk diffusion method by cephalosporin disks as recommended by the CLSI guideline. 10 To confirm ESBL production in E. coli, the method of combination disk diffusion technique was performed. Briefly, disks of ceftazidime (30 µg), ceftazidime/ clavulanate (30/10 µg), cefotaxime (30 µg), and cefotaxime/ clavulanate (30/10 µg) were placed on the Mueller-Hinton agar plate (Difco) with 30 mm distance from the center of each and were incubated at 37°C for 18 hours. The test result is considered as positive if the inhibition zone diameter is 5 mm or larger with clavulanate than without. The strain of Klebsiella pneumoniae ATCC700603 (carrying bla SHV-18 gene) was used for the positive control and E. coli ATCC25922 was used as the negative control in this study.
antimicrobial susceptibility testing
The determination of MIC values was performed by broth microdilution method with nine antimicrobial agents, namely, ciprofloxacin, prulifloxacin, ceftazidime, fosfomycin, imipenem, meropenem, doripenem, biapenem, and piperacillin/ tazobactam. E. coli isolates were grown in Mueller Hinton broth (MH broth), then E. coli isolates were diluted with MH broth to 0.5 McFarland (cell approximately 10 8 CFU/mL), and diluted with normal saline to adjust the cells to 10 6 CFU/ mL before adding into 96-well plates containing antibiotics in triplicates. The working stock concentrations of antibiotics were based on the CLSI guideline. 10 Finally, the plate was kept at 37°C for 18 hours. The results were evaluated by the MIC values from the minimum concentration of the drugs that gave no visible growth.
characterization of esBl genotypes
The standard PCR was performed to screen for the presence of ESBL genes: bla TEM , bla SHV , bla CTX-M , bla OXA , bla GES , bla VEB, and bla PER using specific primers described in Table 1 . PCR reactions contained 1× buffer, 1.5 mM of MgCl 2 , 400 µM of dNTPs, 0.5 µM of forward and reverse primers each, 1 U Taq polymerase, and the concentration of DNA template depending on specific primers. For PCR cycling condition, the denaturation step was achieved at 96°C for 30 seconds, followed by the annealing step, the temperature of which depended upon the specific primers, and the final step of 
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ESBL-encoding genes among E. coli in Thailand extension at 72°C for 30 seconds. All steps were repetitively performed for 30 cycles. Then, the PCR products were analyzed by agarose gel electrophoresis.
Molecular typing by MlsT
Forty-eight strains of ESBL-producing E. coli were selected and determined sequence types by MLST. The criteria for E. coli strain selection were based on ESBL gene pattern. PCR method was used to amplify internal portions of seven housekeeping genes of E. coli (adk, fumC, gyrB, icd, mdh, purA, and recA) with specific primers. Seven-locus MLST was performed using published criteria and primers. 11 Amplification products were submitted to the commercial sequencing service (Macrogen Sequencing, Korea). DNA sequences of each genes were identified using the website: https://pubmlst.org/bigsdb?db=pubmlst_mlst_ seqdef&page=sequenceQuery. The allelic profile for each isolate was determined using the BioNumerics MLST Plug-in in accordance with the Achtman scheme available at http:// enterobase.warwick.ac.uk/species/ecoli/allele_st_search.
Results
Phenotypic detection of esBl-producing E. coli
All 285 E. coli collected from tertiary care hospitals located in various regions in Thailand were determined by combination disk diffusion. Among these positive ESBL-producing E. coli, 55 isolates were from the northeast region, 61 (Figure 1 ). It was of interest that MIC 90 of meropenem and doripenem were about ≤0.125 µg/mL followed by those of biapenem (MIC 90 =0.25 µg/mL) and doripenem (MIC 90 =0.5 µg/mL), respectively ( Table 2 ).
Molecular detection of esBl gene variants
The presence of ESBL genes including bla TEM , bla SHV , bla CTX-M (CTX-M1 and CTX-M9 group), bla OXA (OXA-2 and OXA-10 group), bla GES , bla VEB , and bla PER genes in all clinical isolates were investigated by PCR method (Figure 2 In addition, the coexistence of all three genes mostly was bla CTX-M1 group, bla CTX-M9 group, and bla TEM . Forty-seven strains of ESBL-producing E. coli with high antimicrobial resistance were selected to determine 23 STs using the Achtman MLST scheme. The majority of ST-type high antimicrobial resistant strains was ST38 (10/47 isolates), followed by ST405 (6/47 isolates), ST410 (5/47 isolates), and ST131 (4/47 isolates) ( Table 3) . Among E. coli ST38 isolates, eight strains carried bla PER genes, four strains contained bla GES genes, and two strains possessed bla TEM genes. Interestingly, all of these strains carried bla CTX-M genes and were sensitive to carbapenems, prulifloxacin, and ciprofloxacin. However, 8 out of 10 E. coli ST38 isolates were resistant to ceftazidime and two strains were intermediate sensitive. Most E. coli ST38 strains were sensitive to piperacillin/tazobactam. All of E. coli ST405 contained bla CTX-M genes, while bla VEB could be detected in only two strains and only one strain contained bla TEM gene. E. coli ST405 were sensitive to carbapenems and fosfomycin but were resistant to ceftazidime, prulifloxacin, and ciprofloxacin. All E. coli ST410 carried bla CTX-M and two of them carried bla TEM . Interestingly, only one strain possessed bla OXA and bla VEB genes. This ST type was sensitive to carbapenems and fosfomycin but was resistant to prulifloxacin, ciprofloxacin, ceftazidime, and piperacillin/tazobactam. For E. coli ST131, all of them contained bla CTX-M genes, one strain carried bla TEM , and one strain carried bla VEB . All of these were sensitive to meropenem, doripenem, and fosfomycin. They were resistant to ciprofloxacin, prulifloxacin, and ceftazidime. Two strains of E. coli ST131 were resistant to imipenem and one strain showed intermediate sensitivity to biapenem. Abbreviation: esBl, extended-spectrum β-lactamase. 
Abbreviations: esBl, extended-spectrum β-lactamase; sTs, sequence Types.
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Discussion
ESBLs are bacterial enzymes that mediate resistance to the third-generation cephalosporins and monobactams. The spreading and outbreaks of ESBLs are often found in the family of Enterobacteriaceae especially E. coli. 13 Our findings were based on the evaluation of E. coli strains isolated from clinical specimens obtained from tertiary care hospitals in Thailand. This study clearly showed high resistance rates of ESBL-producing E. coli to ciprofloxacin (85.26%), ceftazidime (80%), and prulifloxacin (79.30%), which raised serious concern and became a challenge for clinicians. In 2013, researchers reported high resistance to cefotaxime, ceftriaxone, and ceftazidime, and only some isolates were resistant to ciprofloxacin while most strains were susceptible to carbapenems in Thailand.
14 In Korea, the study of Kang et al determined antimicrobial susceptibility of ESBLproducing E. coli against imipenem and meropenem and the resistance rates were only 1.5% (1/68) and 0% (0/50), respectively. 15 The previous study in Thailand showed that CTX-M family had the highest prevalence of ESBL-related bla genes (87.3%) similar to our findings in which CTX-M type was still predominant. 12 This study reported the presence of 31.93% bla TEM genes, while in 2011, bla TEM genes were found at 42% and the previous study in 2007 demonstrated 67% bla TEM genes. This indicated that the spreading of bla TEM ESBL-producing E. coli strains were decreased. 16, 17 In addition, only few bla SHV carrying strains were detected by the study of Kiratisin et al in 2007 and our study found only two strains of bla SHV ESBL-producing strains. 16 In India, the prevalence of bla TEM genes was reported at about 48.7% (38/78 strains), followed by bla CTX-M at 7.6% (6/78 strains) and bla SHV at 5.1% (4/78 strains) which were different from our findings in Thailand. 7, 18 This study revealed that the majority of ST type with high antimicrobial resistant rate was ST38 which showed high sensitivity to piperacillin/tazobactam. According to the MLST results described by previous study, ST38 E. coli isolates were identified in China (CTX-M-14 producer), 19 Japan (CTX-M-9 and CTX-M-14 producers), 20 and France (OXA-48 producer). 21 Additionally, Rodríguez et al investigated MLST in bla CTX-M ESBL-producing E. coli from Germany, Netherlands, and UK. The study showed high prevalence of ST38. 22 Moreover, Alghoribi et al found CTX-M-positive ST38, ST131, and ST405 in Saudi Arabia. 23 
Conclusion
This study demonstrated that the CTX-M type remained the most common spreading in Thailand. Although carbapenems remain drugs of choice to treat ESBL-producing bacterial infections, we reported that ESBL-producing E. coli have increased the severity of resistance to antibiotics. It was clearly shown that ESBL outbreaks have been a problem worldwide and we hope to raise the awareness on proper antibiotics use to control spreading of these strains in both hospitals and community.
